> top > docs > PubMed:8845838 > annotations

PubMed:8845838 JSONTXT

Annnotations TAB JSON ListView MergeView

NCBIDiseaseCorpus

Id Subject Object Predicate Lexical cue
T1 1344-1360 SpecificDisease:C536353 denotes VLCAD deficiency
T2 1469-1485 SpecificDisease:C536353 denotes VLCAD deficiency

ncbi-valid-gpt-nr-g

Id Subject Object Predicate Lexical cue
T1 1344-1360 SpecificDisease denotes VLCAD deficiency

ncbi-valid

Id Subject Object Predicate Lexical cue
T1 1344-1360 SpecificDisease denotes VLCAD deficiency
T2 1469-1485 SpecificDisease denotes VLCAD deficiency

ncbi-valid-gpt-nr-ng

Id Subject Object Predicate Lexical cue
T1 1344-1360 SpecificDisease denotes VLCAD deficiency
T2 1469-1485 SpecificDisease denotes VLCAD deficiency

ncbi-valid-gpt-r-ng

Id Subject Object Predicate Lexical cue
T1 1344-1360 SpecificDisease denotes VLCAD deficiency
T2 1469-1485 SpecificDisease denotes VLCAD deficiency

ncbi-valid-gemini-r-g

Id Subject Object Predicate Lexical cue
T1 1344-1360 SpecificDisease denotes VLCAD deficiency

ncbi-valid-gpt-r-g

Id Subject Object Predicate Lexical cue
T1 1344-1360 SpecificDisease denotes VLCAD deficiency
T2 1469-1485 SpecificDisease denotes VLCAD deficiency

ncbi-valid-gemini-nr-ng

Id Subject Object Predicate Lexical cue
T1 193-198 SpecificDisease denotes VLCAD
T2 566-571 SpecificDisease denotes VLCAD
T3 761-766 SpecificDisease denotes VLCAD
T4 1344-1360 SpecificDisease denotes VLCAD deficiency

ncbi-valid-gemini-nr-g

Id Subject Object Predicate Lexical cue
T1 172-192 Modifier denotes mutations within the
T2 1344-1360 SpecificDisease denotes VLCAD deficiency
T3 1571-1580 Modifier denotes mutations

ncbi-valid-deepseek-nr-ng

Id Subject Object Predicate Lexical cue
T1 0-7 CompositeMention denotes Cloning
T2 12-28 CompositeMention denotes characterization
T3 32-37 Modifier denotes human
T4 38-76 SpecificDisease denotes very-long-chain acyl-CoA dehydrogenase
T5 77-81 CompositeMention denotes cDNA
T6 83-105 CompositeMention denotes chromosomal assignment
T7 113-117 CompositeMention denotes gene
T8 122-153 CompositeMention denotes identification in four patients
T9 157-181 CompositeMention denotes nine different mutations
T10 193-203 CompositeMention denotes VLCAD gene
T11 205-243 SpecificDisease denotes Very-long-chain acyl-CoA dehydrogenase
T12 262-266 Modifier denotes four
T13 267-304 SpecificDisease denotes straight-chain acyl-CoA dehydrogenase
T14 306-309 SpecificDisease denotes ACD
T15 311-318 CompositeMention denotes enzymes
T16 334-341 Modifier denotes nuclear
T17 342-349 Modifier denotes encoded
T18 350-363 Modifier denotes mitochondrial
T19 364-377 CompositeMention denotes flavoproteins
T20 378-388 CompositeMention denotes catalyzing
T21 393-400 Modifier denotes initial
T22 401-405 CompositeMention denotes step
T23 409-419 CompositeMention denotes fatty acid
T24 420-434 CompositeMention denotes beta-oxidation
T25 436-438 CompositeMention denotes We
T26 444-448 CompositeMention denotes used
T27 453-462 Modifier denotes very fast
T28 464-469 Modifier denotes Rapid
T29 470-483 CompositeMention denotes Amplification
T30 487-491 CompositeMention denotes cDNA
T31 492-496 CompositeMention denotes Ends
T32 498-502 CompositeMention denotes RACE
T33 504-509 Modifier denotes based
T34 510-518 CompositeMention denotes strategy
T35 522-528 CompositeMention denotes obtain
T36 533-541 CompositeMention denotes sequence
T37 545-550 CompositeMention denotes cDNAs
T38 551-559 CompositeMention denotes encoding
T39 560-565 Modifier denotes human
T40 566-571 SpecificDisease denotes VLCAD
T41 577-585 CompositeMention denotes placenta
T42 590-601 CompositeMention denotes fibroblasts
T43 603-612 CompositeMention denotes Alignment
T44 620-629 Modifier denotes predicted
T45 630-635 CompositeMention denotes amino
T46 636-640 CompositeMention denotes acid
T47 641-649 CompositeMention denotes sequence
T48 653-658 Modifier denotes human
T49 659-664 SpecificDisease denotes VLCAD
T50 670-675 CompositeMention denotes those
T51 683-688 Modifier denotes other
T52 695-698 SpecificDisease denotes ACD
T53 699-706 CompositeMention denotes enzymes
T54 707-715 CompositeMention denotes revealed
T55 716-725 Modifier denotes extensive
T56 726-734 CompositeMention denotes sequence
T57 735-743 CompositeMention denotes homology
T58 745-753 CompositeMention denotes Moreover
T59 777-793 CompositeMention denotes acyl-CoA oxidase
T60 794-800 CompositeMention denotes showed
T61 829-842 CompositeMention denotes corroborating
T62 847-853 CompositeMention denotes notion
T63 859-864 Modifier denotes these
T64 865-870 CompositeMention denotes genes
T65 871-874 CompositeMention denotes are
T66 875-889 Modifier denotes evolutionarily
T67 890-897 CompositeMention denotes related
T68 897-898 CompositeMention denotes .
T69 899-912 CompositeMention denotes Southern blot
T70 913-921 CompositeMention denotes analysis
T71 925-932 Modifier denotes genomic
T72 933-936 CompositeMention denotes DNA
T73 942-948 Modifier denotes hybrid
T74 949-953 CompositeMention denotes cell
T75 954-959 CompositeMention denotes lines
T76 960-963 CompositeMention denotes was
T77 964-968 CompositeMention denotes used
T78 972-980 CompositeMention denotes localize
T79 985-990 SpecificDisease denotes VLCAD
T80 999-1004 Modifier denotes human
T81 1005-1015 CompositeMention denotes chromosome
T82 1016-1018 CompositeMention denotes 17
T83 1018-1019 CompositeMention denotes p
T84 1019-1021 CompositeMention denotes 11
T85 1021-1022 CompositeMention denotes .
T86 1022-1027 CompositeMention denotes 2-p11
T87 1028-1033 CompositeMention denotes 13105
T88 1035-1040 CompositeMention denotes Using
T89 1041-1049 CompositeMention denotes Northern
T90 1054-1061 CompositeMention denotes Western
T91 1062-1066 CompositeMention denotes blot
T92 1067-1075 CompositeMention denotes analysis
T93 1079-1090 CompositeMention denotes investigate
T94 1095-1101 Modifier denotes tissue
T95 1102-1110 Modifier denotes specific
T96 1111-1123 CompositeMention denotes distribution
T97 1127-1132 SpecificDisease denotes VLCAD
T98 1133-1137 CompositeMention denotes mRNA
T99 1142-1149 CompositeMention denotes protein
T100 1153-1160 Modifier denotes several
T101 1161-1166 Modifier denotes human
T102 1167-1174 CompositeMention denotes tissues
T103 1178-1184 CompositeMention denotes showed
T104 1190-1195 SpecificDisease denotes VLCAD
T105 1199-1203 Modifier denotes most
T106 1204-1212 CompositeMention denotes abundant
T107 1216-1221 CompositeMention denotes heart
T108 1226-1234 Modifier denotes skeletal
T109 1235-1241 CompositeMention denotes muscle
T110 1243-1247 CompositeMention denotes This
T111 1248-1254 CompositeMention denotes agrees
T112 1255-1259 Modifier denotes well
T113 1269-1273 CompositeMention denotes fact
T114 1279-1286 Modifier denotes cardiac
T115 1298-1306 CompositeMention denotes symptoms
T116 1311-1325 CompositeMention denotes characteristic
T117 1330-1338 CompositeMention denotes patients
T118 1344-1349 SpecificDisease denotes VLCAD
T119 1350-1360 DiseaseClass denotes deficiency
T120 1362-1370 CompositeMention denotes Northern
T121 1371-1375 CompositeMention denotes blot
T122 1376-1384 CompositeMention denotes analysis
T123 1389-1399 CompositeMention denotes sequencing
T124 1403-1409 Modifier denotes cloned
T125 1410-1413 CompositeMention denotes PCR
T126 1414-1423 Modifier denotes amplified
T127 1430-1434 CompositeMention denotes cDNA
T128 1440-1444 Modifier denotes four
T129 1445-1454 Modifier denotes unrelated
T130 1455-1462 CompositeMention denotes patient
T131 1469-1474 SpecificDisease denotes VLCAD
T132 1486-1492 CompositeMention denotes showed
T133 1504-1508 CompositeMention denotes mRNA
T134 1513-1525 CompositeMention denotes undetectable
T135 1533-1540 Modifier denotes patient
T136 1554-1559 Modifier denotes other
T137 1560-1565 Modifier denotes three
T138 1566-1570 CompositeMention denotes have
T139 1571-1580 CompositeMention denotes mutations
T140 1584-1588 Modifier denotes both
T141 1589-1594 SpecificDisease denotes VLCAD
T142 1595-1602 CompositeMention denotes alleles
T143 1604-1611 CompositeMention denotes Western
T144 1612-1616 CompositeMention denotes blot
T145 1617-1625 CompositeMention denotes analysis
T146 1637-1648 CompositeMention denotes fibroblasts
T147 1665-1675 Modifier denotes identified
T148 1686-1692 CompositeMention denotes result
T149 1696-1704 Modifier denotes severely
T150 1705-1712 CompositeMention denotes reduced
T151 1713-1720 CompositeMention denotes amounts
T152 1730-1737 CompositeMention denotes protein

ncbi-valid-deepseek-nr-g

Id Subject Object Predicate Lexical cue
T1 0-7 Modifier denotes Cloning
T2 32-76 SpecificDisease denotes human very-long-chain acyl-CoA dehydrogenase
T3 77-81 Modifier denotes cDNA
T4 193-198 SpecificDisease denotes VLCAD
T5 267-304 SpecificDisease denotes straight-chain acyl-CoA dehydrogenase
T6 306-309 SpecificDisease denotes ACD
T7 334-377 Modifier denotes nuclear encoded mitochondrial flavoproteins
T8 409-434 DiseaseClass denotes fatty acid beta-oxidation
T9 498-502 Modifier denotes RACE
T10 577-585 Modifier denotes placenta
T11 590-601 Modifier denotes fibroblasts
T12 683-706 CompositeMention denotes other human ACD enzymes
T13 761-766 SpecificDisease denotes VLCAD
T14 771-793 SpecificDisease denotes human acyl-CoA oxidase
T15 999-1021 Modifier denotes human chromosome 17p11
T16 1027-1029 Modifier denotes .1
T17 1041-1049 Modifier denotes Northern
T18 1054-1061 Modifier denotes Western
T19 1133-1137 Modifier denotes mRNA
T20 1142-1149 Modifier denotes protein
T21 1161-1166 Modifier denotes human
T22 1216-1221 Modifier denotes heart
T23 1226-1241 Modifier denotes skeletal muscle
T24 1279-1286 Modifier denotes cardiac
T25 1330-1360 CompositeMention denotes patients with VLCAD deficiency
T26 1362-1370 Modifier denotes Northern
T27 1403-1409 Modifier denotes cloned
T28 1410-1413 Modifier denotes PCR
T29 1430-1434 Modifier denotes cDNA
T30 1440-1485 CompositeMention denotes four unrelated patients with VLCAD deficiency
T31 1504-1508 Modifier denotes mRNA
T32 1589-1594 SpecificDisease denotes VLCAD
T33 1595-1602 Modifier denotes alleles
T34 1604-1611 Modifier denotes Western
T35 1629-1648 CompositeMention denotes patient fibroblasts
T36 1724-1729 SpecificDisease denotes VLCAD
T37 1730-1737 Modifier denotes protein

ncbi-valid-deepseek-r-g

Id Subject Object Predicate Lexical cue
T1 1344-1360 SpecificDisease denotes VLCAD deficiency

ncbi-valid-deepseek-r-ng

Id Subject Object Predicate Lexical cue
T1 38-76 CompositeMention denotes very-long-chain acyl-CoA dehydrogenase
T2 409-434 DiseaseClass denotes fatty acid beta-oxidation
T3 1344-1360 SpecificDisease denotes VLCAD deficiency

ncbi-valid-gemini-r-ng

Id Subject Object Predicate Lexical cue
T1 1279-1306 DiseaseClass denotes cardiac and muscle symptoms
T2 1344-1360 SpecificDisease denotes VLCAD deficiency

ncbi-valid-gemini-r-m

Id Subject Object Predicate Lexical cue
T1 1344-1360 SpecificDisease denotes VLCAD deficiency

ncbi-valid-gpt-r-m

Id Subject Object Predicate Lexical cue
T1 1344-1360 SpecificDisease denotes VLCAD deficiency
T2 1469-1485 SpecificDisease denotes VLCAD deficiency

ncbi-valid-deepseek-r-m

Id Subject Object Predicate Lexical cue
T1 1344-1360 SpecificDisease denotes VLCAD deficiency

NCBI-Disease-Develop

Id Subject Object Predicate Lexical cue database_id
T746 1344-1360 SpecificDisease denotes VLCAD deficiency C536353
T747 1469-1485 SpecificDisease denotes VLCAD deficiency C536353

NCBI-Disease-Corpus-All

Id Subject Object Predicate Lexical cue database_id
T746 1344-1360 SpecificDisease denotes VLCAD deficiency C536353
T747 1469-1485 SpecificDisease denotes VLCAD deficiency C536353

NCBI-Disease-Corpus-2stage-All

Id Subject Object Predicate Lexical cue
T2 1344-1360 SpecificDisease denotes VLCAD deficiency
T3 1469-1485 SpecificDisease denotes VLCAD deficiency

NCBI-Disease-Corpus-rezarta-All

Id Subject Object Predicate Lexical cue
T1 1344-1360 SpecificDisease denotes VLCAD deficiency
T2 1469-1485 SpecificDisease denotes VLCAD deficiency

NCBI-Disease-Corpus-4oGuideline-All

Id Subject Object Predicate Lexical cue
T2 1344-1360 SpecificDisease denotes VLCAD deficiency
T3 1469-1485 SpecificDisease denotes VLCAD deficiency

NCBI-Disease-Corpus-Simple-All

Id Subject Object Predicate Lexical cue
T1 245-250 SpecificDisease denotes VLCAD
T2 1279-1297 Modifier denotes cardiac and muscle
T3 1344-1360 SpecificDisease denotes VLCAD deficiency
T4 1469-1485 SpecificDisease denotes VLCAD deficiency